CHRM3 is a novel prognostic factor of poor prognosis and promotes GBM progression via activation of oncogenic invasive growth factors
Ontology highlight
ABSTRACT: CHRM3 is a novel prognostic factor of poor prognosis and promotes GBM progression via activation of oncogenic invasive growth factors
PROVIDER: PRJNA908781 | ENA |
REPOSITORIES: ENA
ACCESS DATA